Skip to main content
SpringerLink
Log in
SpringerLink
Log in

Erkrankungen der Atemwege

  • Chapter
Pharmakotherapie

Part of the book series: Springer-Lehrbuch ((SLB))

  • 282 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Weiterführende Literatur

  • Adam D et al. (1991) Antibakterielle Therapie bei infektiösen Bronchialerkrankungen. MMW 133: 308

    Google Scholar 

  • Agence Francaise de Sécurité Sanitaire des Produits de Santé (2001) Troubles de la sécrétion bronchique. www.agmed.sante.gouv.fr/htm/5/smr/pneumo/sebron2.htm. Abgerufen 2003

    Google Scholar 

  • Agertoft L, Pedersen S (1994) Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Resp. Med. 88: 373

    Article  CAS  Google Scholar 

  • Cumming RG, Mitchell P, Leeder SR (1997) Use of inhaled corticosteroids and the risk of cataracts. New Engl. J. Med. 337: 8

    Article  PubMed  CAS  Google Scholar 

  • Drazen JM, Israel E, O’Byrne PM (1999) Treatment of asthma with drugs modifying the leukotrien pathway. New Engl. J. Med. 340: 197

    Article  PubMed  CAS  Google Scholar 

  • Global Initiative for Chronic Obstructive Lung Disease (GOLD) (2001) Am J Respir Crit Care Med 163:1256–1276, http://www.goldcopd.comp/html

    Google Scholar 

  • International Rhinitis Management Working Group (1994) International Consensus Report on the Diagnosis and Management of Rhinitis. Allergy 49:Suppl 1

    Google Scholar 

  • Johnson M (1996) Pharmacodynamics and phamacokinetics of inhaled glucocorticoids: J. Allergy Clin. Immunol. 97: 169

    Article  PubMed  CAS  Google Scholar 

  • Kroegel C, König W, Jäger L (1997) Erweiterte Therapie des Asthma bronchiale — Verwendung von 5-Lipoxygenase-Inhibitoren und Leukotrienantagonisten. Dtsch. Ärztebl. 94: A1802

    Google Scholar 

  • Leitlinien COPD (2002): http://www.leitlinien.de/themen/infocopd.htm

    Google Scholar 

  • Mullen ML, Mullen B, Carey M (1993) The association between β-agonist use and death from asthma. JAMA 270: 1842

    Article  PubMed  CAS  Google Scholar 

  • National Heart, Lung, and Blood Institute (1997) Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma [EPR-2]. National Institutes of Health, pub. no. 97-4051

    Google Scholar 

  • National Institutes of Health, National Heart, Lung, and Blood Institute (2003) Pocket Guide to COPD Diagnosis, Management, and Prevention, http://www.goldcopd.comp.

    Google Scholar 

  • National Asthma Education and Prevention Program Expert Panel Report (2002) Guidelines for the Diagnosis and Management of Asthma Update on Selected Topics-2002. J Allergy Clin Immunol 110: part 2. http://www2.us.elsevierhealth.com/scripts/om.dll_serve?action=searchDB&searchDBfor=iss&id=jai021105b

    Google Scholar 

  • Poole PJ, Black PN (2003) Mucolytic agents for chronic bronchitis (Cochrane Review). In: The Cochrane Library, Issue 1, Oxford: Update Software

    Google Scholar 

  • Schmidt H (1994) Retardtheophyllin ist nicht gleich Retardtheophyllin. Atemwegs-Lungenkr. 20: 223–231

    Google Scholar 

  • Slater JW, Zechnich AD, Haxby DG (1999) Second-generation antihistamines — a comparative review. Drugs 57: 31

    Article  PubMed  CAS  Google Scholar 

  • Smolensky MH, D’Alonso GE (1997) Progress in the chronotherapy of nocturnal asthma. In: Redfern P., Lemmer B. (eds.): Physiology and Pharmacology of Biological Rhythms. Handbook of Experimental Pharmacology, Vol. 125, Springer, Berlin, Heidelberg, New York, pp. 205–249

    Google Scholar 

  • Wettengel R et al. (1998) Asthmatherapie bei Kindern und Erwachsenen. Empfehlungen der Deutschen Atemwegsliga in der Deutschen Gesellschaft für Pneumologie. Med. Klinik 93: 639–650

    Article  CAS  Google Scholar 

  • WHO Collaborating Centre for Drug Statistics Methodology (2000) ATC Index with DDDs. Oslo

    Google Scholar 

  • Worth H et al. (2002) Leitlinie der Deutschen Atemwegsliga und der Deutschen Gesellschaft für Pneumologie zur Diagnostik und Therapie von Patienten mit chronisch obstruktiver Bronchitis und Lungenemphysem (COPD). Pneumologie 56:704–738

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut für Pharmakologie und Toxikologie Fakultät für Klinische Medizin, Mannheim Ruprecht-Karls-Universität Heidelberg, Maybachstraße 14-16, 68169, Mannheim

    Prof. Dr. med. Dr. h.c. B. Lemmer

  2. Schillbachstraße 13, 07743, Jena

    Prof. Dr. med. R. Wettengel

Authors
  1. Prof. Dr. med. Dr. h.c. B. Lemmer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prof. Dr. med. R. Wettengel
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer-Verlag Heidelberg

About this chapter

Cite this chapter

Lemmer, B., Wettengel, R. (2004). Erkrankungen der Atemwege. In: Pharmakotherapie. Springer-Lehrbuch. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-35149-3_21

Download citation

  • DOI: https://doi.org/10.1007/3-540-35149-3_21

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-20414-5

  • Online ISBN: 978-3-540-35149-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation